Mormodica charantia L. Leaf Alleviates Menstrual Cycle Disruption and Hormonal Fluctuations In Letrozole-Induced Polycystic Ovarian Syndrome Rat
Article Sidebar
Main Article Content
Abstract
Polycystic ovarian syndrome affects 7 to 10% of women. To manage PCOS in women without lowering the likelihood of becoming pregnant, researchers are looking for botanicals with antioxidant potential, optimum bioavailability, efficacy, and safety. Therefore, this research investigated the effect of Mormodica charantia leaves on PCOS in rats. The toxicity of the crude extract was evaluated using Brine shrimp larva. The total phenolic and flavonoid contents (TPC and TFC), as well as the antioxidant activity of the extract and solvent fractions (n-hexane, DCM, and ethyl acetate), were evaluated using established methods. Methanol extract and clomiphene citrate were administered to the letrozole-induced PCOS albino rat. The methanol extract's LC50 value was 1818.79±0.22 μg/mL. The hexane fraction had a significant antioxidant activity (IC50 = 37.06±0.11 μg/mL). The methanol extract reduced the levels of luteinizing hormone and increased follicle-stimulating hormone, as well as estradiol levels in PCOS rats. The ovary of M. charantiatreated rat had normal thecal cells and granular cell hyperplasia. Thus, M. charantia leaf has a beneficial impact on menstrual cycle disruption as well as hormonal fluctuations associated with PCOS. Therefore, Mormodica charantia leaves may have the potential to reduce the risk of PCOS in women.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Teede HJ, Tay CT, Laven JJ, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ. Recommendations from the 2023 international evidencebased guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189(2): G43-64.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(l):19-25.
Amini L, Tehranian N, Movahedin M, Tehrani FR, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials. Iran J Reprod Med. 2015; 13(1):1-8.
Xu W, Zuo T, Zhu M. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev. 20l6; 20l6(l): l-l4.
Badawy A and Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 20ll; 3(l): 25-35.
Bates GW and Legro RS. Longterm management of polycystic ovarian syndrome (PCOS). Mol Cell Endocrinol. 20l3; 373(l-2): 9l-97.
Sonibare MA and Ayoola IO. Medicinal plants used in the treatment of neurodegenerative disorders in some parts of Southwest Nigeria. Afr J Pharm Pharmacol. 20l5; 9(38): 956-965.
Ogunlakin AD, Sonibare MA, Yeye OE, Jabeen A, Shah SF, Ojo OA, Gyebi GA, Ayokunle DI. Design, Synthesis, and Characterization of Cinnamic Acid Derivatives with Two Novel Acrylohydrazones on HeLa and CHO-1 Cancer Cell Lines: The Experimental and Computational Perspective.
Chem Afr. 2024; 7:583-604.
Pahlavani N, Roudi F, Zakerian M, Ferns GA, Navashenaq JG, Mashkouri A, Ghayour‐Mobarhan M, Rahimi H. Possible molecular mechanisms of glucose‐lowering activities of Momordica charantia (karela) in diabetes. J Cell Biochem. 2019; 120(7):10921-10929.
Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. J Ethnopharmacol. 2019; 231:311-324.
Liu Z, Gong J, Huang W, Lu F, Dong H. The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review. eCAM. 2021; 16(2021):3796265.
Zhang F, Zhang X, Yu J, Tan Y, Guo P, Wu C. The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) in high-fat diet (HFD)-induced hyperlipidemic mice. Biomed Pharmacother. 2020; 131:110667.
Ogunlakin AD and Sonibare MA. Ethnobotanical survey of medicinal plants used as remedy for female infertility and menstrual disorder in southwestern Nigeria. Niger J Pharm Res. 2019; 15(2):205-217.
McLaughlin JL, Rogers LL, Anderson JE. The use of biological assays to evaluate botanicals. Drug Inf J, l998; 32(l): 5l3-524.
Bursal E and Gülçin I. Polyphenol content and in vitro antioxidant activities of lyophilized aqueous extract of kiwifruit (Actinidia deliciosa). Food Res Int. 20ll; 44(5): l482–l489.
Miliauskas G, Venskutonis PR, Van BTA. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem. 2004; 85(2):23l–237.
Woisky R and Salatino A. Analysis of Propolis: some parameter and procedures for chemical quality control. J Apicult Sci, l988; 37(2): 99–l05.
Ogunlakin AD, Sonibare MA, Yeye OE, Gyebi GA, Ayokunle DI, Arigbede OE, Ibrahim IM, Odugbemi AI, Jabeen A, Shah SF, Shaheen F. Isolation and characterization of novel hydroxyflavone from Kigelia africana (Lam.) Benth. fruit ethyl acetate fraction against CHO 1 and HeLa cancer cell lines: In vitro and in silico studies. J Mol Struct. 2023; 1282:135180.
Nair AB and Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 20l6; 7(2):27-3l.
Ojo OA, Grant S, Amanze JC, Oni AI, Ojo AB, Elebiyo TC, Obafemi TO, Ayokunle DI, Ogunlakin AD. Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic β-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes. PLoS ONE,
; 17(10):e0276984.
Rana S, Hussain L, Saleem U, Asif M, Lodhi AH, Barkat MQ, Riaz M, Jamil A. Dose Dependent Effects of Aqueous Extract of Garcinia cambogia Desr. Against Letrozole Induced Polycystic Ovarian Syndrome in Female Adult Rats With Possible Mechanisms Exploration. Dose Response.
; 21(2):15593258231169381.
Shehab NG, Anbar HS, Alrouby NM, Abouelalamin A, Lutfi L, Allo IT, Elayoty SM. New alternative herbal remedies for treatment of letrozole-induced polycystic ovary syndrome in rats. J Appl Pharm Sci. 2023; 13(1):163-179.
Avwioro OG. Histochemistry and tissue pathology - Principles and Techniques. Textbook of Histochemistry and Tissue Pathology,” 2nd Edition, Claverianun Press, Ibadan, Nigeria. 20l0.
Campbell DL, Lawton LA, Beattie KA, Codd GA. Comparative assessment of the specificity of the brine shrimp and microtox assays to hepatotoxic (microcystin-LRcontaining) cyanobacteria. Environ Toxicol, l994; 9(l): 7l77.
Alamgir AN. Therapeutic use of medicinal plants and their extracts: volume 1. Springer International Publishing AG.; 2017.
Niksic H, Becic F, Koric E, Gusic I, Omeragic E, Muratovic S, Miladinovic B, Duric K. Cytotoxicity screening of Thymus vulgaris L. essential oil in brine shrimp nauplii and cancer cell lines. Sci Rep. 2021; 11(1):13178.
Cock IE, Luwaca N, Van Vuuren SF. The traditional use of Southern African medicinal plants to alleviate fever and their antipyretic activities. J Ethnopharmacol. 2023; 303:115850.
El-Beltagi HS, Mohamed AA, Mohamed HI, Ramadan KM, Barqawi AA, Mansour AT. Phytochemical and potential properties of seaweeds and their recent applications: A review. Marine Drugs. 2022; 20(6):342.
Hassanpour SH and Doroudi A. Review of the antioxidant potential of flavonoids as a subgroup of polyphenols and partial substitute for synthetic antioxidants. Avicenna J Phytomed. 2023; 13(4):354.
Aryal S, Baniya MK, Danekhu K, Kunwar P, Gurung R, Koirala N. Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from Western Nepal. Plants. 2019; 8(4):96.
Hussain T, Fatima I, Rafay M, Shabir S, Akram M, Bano S. Evaluation of antibacterial and antioxidant activity of leaves, fruit and bark of Kigelia africana. Pak J Bot, 20l6; 48(l): 277-283.
Zhang C, Feng S, Wang Q, Wang P, Xu J, Chen T. Flavonoids and phenolic compounds from Smilax scobinicaulis. Chem Nat Compd, 20l4; 50(2): 254-257.
Sonibare MA, Onifade TR, Ogunlakin AD, Akinmurele OJ, Adebodun SA. Microscopic Evaluation and Antioxidant Activity of Glyphaea brevis (Spreng.) Monach (Family Tiliaceae). Free Radic Antioxid. 2022; 12(1):27-32.
Choi JE, Kang SH, Lee SJ, Bae YK. Androgen receptor expression predicts decreased survival in early stage triplenegative breast cancer. Ann Surg Oncol, 20l5; 22(l): 82-89.
Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018; 32(3):271-281.
Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab. 2018; 29(11):768-780.
Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020; 35:100937.
Ye W, Xie T, Song Y, Zhou L. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021; 25(4):1825-1837.
Kumariya S, Ubba V, Jha RK, Gayen JR. Autophagy inovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy, 2021;17(10):2706-2733.
Jozkowiak M, Piotrowska-Kempisty H, Kobylarek D, Gorska N, Mozdziak P, Kempisty B, Rachon D, Spaczynski RZ. Endocrine disrupting chemicals in polycystic ovary syndrome: the relevant role of the theca and granulosa cells in the pathogenesis of the ovarian dysfunction. Cells. 2022; 12(1):174.
Ogunlakin AD and Sonibare MA. Phytochemistry and biological activities of Tetracera species. Trends Phytochem Res. 2022; 6(4): 339-352.
Ogunlakin AD, Sonibare MA, Ojo OA. Review on Effect of Medicinal Plants on Female Reproductive System. Trop J Nat Prod Res. 2023; 7(3): 2473-2483.